Posted in | News | Plastics and Polymers

ExxonMobil Chemical Offer New Battery Film for Electric Vehicles

ExxonMobil Chemical today announced that its new battery film technology will be an integral part of Electrovaya’s new all electric vehicles. ExxonMobil’s battery separator films significantly enhance the power, safety and reliability of lithium-ion batteries, thereby helping speed the adoption of these smaller and lighter batteries into the next wave of lower-emission vehicles. Electrovaya announced the launch of its Zero Emission Low Speed vehicle, Maya-300, earlier today.

“ExxonMobil is pleased to collaborate with Electrovaya,” said Jim Harris, senior vice president, ExxonMobil Chemical. “ExxonMobil’s film technologies allow lithium-ion batteries to meet hybrid and electric vehicle requirements, helping to make vehicles like the Maya-300 lighter and more efficient.”

The Maya-300 electric vehicles will have an extended range of up to 120 miles and are designed for urban and neighborhood driving patterns.

“Electrovaya’s innovative lithium-ion battery system has made the low-speed electric vehicle a viable commercial product,” said Sankar Das Gupta, chief executive officer, Electrovaya. “We are pleased to launch the Maya-300 and believe this zero emission vehicle marks a new era where affordable clean transportation solutions become available with sufficient range for daily local driving.”

ExxonMobil’s technology platform builds on twenty years experience in lithium-ion battery separators, applying advanced polymer and process technologies with flexibility to tailor products to battery manufacturer requirements.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.